Company / Operating Income per Share
PLUS THERAPEUTICS, INC. Operating Income per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.49
FY2025
5-year range
-$3.58 / -$0.10
FY2021-FY2025
Trend
+16.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-3.58 in FY2018 to $-0.10 in FY2017.
Based on SEC 10-K filings.
-2.49 in FY2025.
Improved from $-3.58 to $-2.49 over the past 7 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 16.9% year-over-year.
- Peak operating income per share was recorded in FY2017.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.49 | +16.9% |
| FY2024 | -$3.00 | +16.2% |
| FY2018 | -$3.58 | -3530.1% |
| FY2017 | -$0.10 | +91.6% |
| FY2016 | -$1.18 | -280.7% |
| FY2015 | -$0.31 | +22.5% |
| FY2014 | -$0.40 | +10.7% |
| FY2013 | -$0.45 | +0.3% |
| FY2012 | -$0.45 | -7.9% |
| FY2011 | -$0.41 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026